da Rocha Bruno Simas, Silveira Vitor Bock, Rados Dimitris Varvaki, Zanella André Borsato, Scheffel Rafael Selbach, Maia Ana Luiza, Dora Jose Miguel
Clinical Pharmacy Division, Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil.
Thyroid Unit, Hospital de Clínicas de Porto Alegre, Medical School, Universidade Federal do Rio Grande do Sul, Porto Alegre, Rio Grande do Sul, Brazil.
Endocrine. 2025 Apr 12. doi: 10.1007/s12020-025-04229-4.
Treatment adherence for chronic conditions is a common clinical challenge. This systematic review aimed to assess the impact of scheduling and timing on levothyroxine adherence in patients with hypothyroidism.
We searched multiple databases (PubMed, EMBASE, SCOPUS, Web Of Science, and CINAHL) using relevant terms related to hypothyroidism and medication adherence. Two independent reviewers conducted study selection, evaluation, and data extraction. The primary outcome was thyrotropin (TSH) levels, analyzed using inverse-variance meta-analysis. Trial sequential analysis (TSA) was conducted to assess the statistical reliability of the meta-analyses results.
Of the 706 articles initially found, 11 met the inclusion criteria: eight assessed evening administration and three evaluated weekly administration of levothyroxine. Comparison between evening and morning administration showed no significant difference in changes of TSH levels (dTSH 0.18; 95% confidence interval [95%CI] -0.29-0.65, P = 0.46). However, considering weekly administration of levothyroxine, TSH levels were higher in the experimental group (dTSH 1.14; 95%CI 0.80-1.14, P < 0.01), although the mean final TSH remained within the reference range in both groups. TSA indicated that the required information size was achieved for scheduling interventions.
Both daily timing and weekly administration of levothyroxine were effective in maintaining TSH levels within reference values. Individualized dosing regimens may be considered based on patient convenience and preference.
慢性病的治疗依从性是常见的临床挑战。本系统评价旨在评估给药计划和时间安排对甲状腺功能减退患者左甲状腺素依从性的影响。
我们使用与甲状腺功能减退和药物依从性相关的相关术语搜索了多个数据库(PubMed、EMBASE、SCOPUS、Web of Science和CINAHL)。两名独立的评审员进行了研究选择、评估和数据提取。主要结局是促甲状腺激素(TSH)水平,采用逆方差荟萃分析进行分析。进行了试验序贯分析(TSA)以评估荟萃分析结果的统计可靠性。
在最初找到的706篇文章中,11篇符合纳入标准:8篇评估了左甲状腺素的晚间给药,3篇评估了左甲状腺素的每周给药。晚间给药与早晨给药的比较显示TSH水平变化无显著差异(dTSH 0.18;95%置信区间[95%CI] -0.29-0.65,P = 0.46)。然而,考虑左甲状腺素的每周给药,实验组的TSH水平较高(dTSH 1.14;95%CI 0.80-1.14,P < 0.01),尽管两组的最终TSH均值均保持在参考范围内。TSA表明达到了计划干预所需的信息量。
左甲状腺素的每日给药时间和每周给药在将TSH水平维持在参考值内均有效。可根据患者的便利性和偏好考虑个体化给药方案。